Joe G.N. “Skip” Garcia, MD
FOUNDER & CHIEF EXECUTIVE OFFICER
Joe G. N. "Skip" Garcia, MD, is an internationally-noted pulmonary physician-scientist, an endowed professor of medicine at the University of Arizona College of Medicine – Tucson, and an elected member of the National Academy of Medicine. A noted academic health system administrator, scholar and educator, Dr. Garcia is a leading authority on the genetic basis of lung disease and the prevention and treatment of inflammatory lung injury. Dr. Garcia is internationally recognized for development of novel biomarkers and therapies for critically ill patients with acute inflammatory lung disease and for addressing health disparities in vulnerable populations. He has over 575 peer-reviewed publications, an expansive portfolio of NIH-sponsored research, and continues to direct large federally-funded programs.
Stan Miele, BA
PRESIDENT
A recognized global executive with success in sales, marketing and P&L leadership in the pharmaceutical/medical device and biotech industries. Mr. Miele was formally the Chief Commercial Officer at bioLytical Laboratories and Sucampo Pharmaceuticals Inc. He was also President of Sucampo Pharma Americas for 6 years. He was instrumental on some key licensing agreements for Sucampo, inclusive of the agreement with Abbott Japan, and also Takeda Pharmaceuticals (now Shire). He is actively part of the team ensuring proper execution of clinical development, manufacturing, licensing, capital funding, alliances, and ensuring Aqualung meets all critical milestones. He will be helping the company move toward accelerating the pipeline/platform technology and moving eNamptor™ toward commercialization.
Mariam Morris
CHIEF FINANCIAL OFFICER
Ms. Morris serves as Aqualung’s CFO, since October 2018. Prior to Aqualung, she served as the Chief Financial Officer of Cerecor from May 2015 through August 2018. While at Cerecor, she completed the Company’s IPO and raised over $28 million in financings, in-licensed and out-licensed key assets, and completed two corporate acquisitions. She was responsible for the Company’s financial and corporation operations, investor relations, and served as the board’s secretary. Prior to joining Cerecor, Ms. Morris was the sole proprietor of Mariam Morris CPA, a full-service tax, accounting and business consulting firm, which she founded in January 2009 and operated until May 2015 where she served as an advisor to many private and public biotechnology companies. She served as the Chief Financial Officer of Sucampo Pharmaceuticals, Inc. from February 2004 to July 2009, where she completed the Company’s IPO and raised over $56 million in financings. From 1991 until 2001, Ms. Morris was and managing auditor for PricewaterhouseCoopers. Ms. Morris received her B.B.A. in Accounting from Texas Tech University and her M.S. in Taxation from Old Dominion University. Ms. Morris is a Certified Public Accountant in the State of Texas and a member of the TSCPA and AICPA.
Outstanding Consultants on the Aqualung Team
WuXi Biologics- CMC, mAb Manufacturing
Prevail Infoworks - Clinical Trials
Beyond Drug development Clinical Trials, FDA IND filing, IND-enabling Tox studies
MRIGLobal- Acute IND-enabling studies
Agilex- Chronic IND-enabling studies
Process Development, Manufacturing Support, Non-Clinical Regulatory Guidance